DAAN Biotherapeutics
Seoul
About DAAN Biotherapeutics
DAAN Biotherapeutics develops novel treatments for cancer patients. The company conducts cancer treatment research and development, including cell therapies, antibodies, and small molecule inhibitors.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $21.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2024)
- Website: daanbiotpx.com
- Phone: 02-6222-3170
Industries & Categories
Biotechnology, Health Care, Therapeutics
Canonical: https://fsome.com/organization/daan-biotherapeutics-152298 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.